Do Analysts Agree Monday on Kala Pharmaceuticals Inc (KALA) Stock's Target Price?

Wall Street is positive on Kala Pharmaceuticals Inc (KALA). On average, analysts give KALA a Strong Buy rating. The average price target is $19.857, which means analysts expect the stock to increase by 418.46% over the next twelve months. That average ranking earns KALA an Analyst Rating of 65, which is better than 65% of stocks based on data compiled by InvestorsObserver.

Wall Street analysts are rating KALA a Strong Buy today. Find out what this means to you and get the rest of the rankings on KALA!

See Full KALA Report

Why are Analyst Ratings Important?

Analysts know the inner workings of the companies they follow better than anyone but the companies’ management. You can learn a lot about a company from studying the financial statements, but analysts ask questions on conference calls and understand the intricacies of each of the businesses they cover. Analysts understand how bad weather in one part of the world can disrupt supply chains, or disrupt shopping patterns. This lets traders make decisions **before** a quarterly report that could be worse than expected. InvestorsObserver aggregates the ratings of all the analysts covering a given stock, takes the average of those ratings and then percentile ranks the averages. That provides a level of granularity that is significantly better than just the three levels provided by traditional buy/hold/sell ratings.

What's Happening With Kala Pharmaceuticals Inc Stock Today?

Kala Pharmaceuticals Inc (KALA) stock is up 0.66% while the S&P 500 has fallen -1.86% as of 1:10 PM on Monday, Jul 19. KALA has gained $0.03 from the previous closing price of $3.80 on volume of 1,168,526 shares. Over the past year the S&P 500 is up 30.59% while KALA has fallen -64.67%. KALA lost -$1.96 per share the over the last 12 months. Click Here to get the full Stock Report for Kala Pharmaceuticals Inc stock.